/Investor DB

InCube Ventures — Full Portfolio

25 tracked investments · listed companies and verified rows first

Rani Therapeutics HoldingsNASDAQ: RANIOct 2025SEC filingmedium confidence

Rani Therapeutics is a clinical-stage biopharmaceutical company developing oral delivery technologies for biologics and drugs, primarily through its proprietary RaniPill capsule platform, which comes in two configurations (RaniPill GO for up to 3 mg microtablet doses and RaniPill HC for up to 200µL liquid doses).

BiotechSan Jose, US

Talat Imran(Executive Officer, Director)inSvai Sanford(Executive Officer)inMir Hashim(Executive Officer)in

BoardAbraham Bassan(Director)Vasudev Bailey, M.D.(Director)

Board seatMir Imran· per SEC Form D · $60.3M raise · filed Nov 2025

Co-investorsRA Capital

Rani Therapeuticsranitherapeutics.cominNASDAQ: RANI

Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles.

BiotechDigital HealthHealthtechMedical DevicesSan Jose, US

Mir Hashim(Executive Officer, Director)inTalat Imran(Chief Executive Officer)in

BoardMir Imran(Founder)Andrew Farquharson(Director)in

Co-investorsGV (Google Ventures)RA CapitalVHM

Neptune Medicalneptunemedical.comin✓ verified

Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation.

HealthtechMedical DevicesRoboticsSilicon Valley, US

Alex Tilson(Founder & CEO)in

Co-investorsSonder CapitalMighty CapitalShangBay Capital LLC

Metagenomimetagenomi.coin𝕏

Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations.

BiotechDeep TechMedical DevicesBerkeley, US

Brian Thomas(Executive Officer, Director, Promoter)in

BoardAndrew Farquharson(Director)inJak Knowles(Director)

Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more

Tassotassoinc.comin𝕏Dec 2021

Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.

Digital HealthHealthtechMedical DevicesSeattle, US

Ben Casavant(Co-Founder and Chief Executive Officer)inErwin Berthier(Co-Founder and Chief Technology Officer)inAlan Levy(Director)

BoardElizabeth Hambrecht(Director)Paul Conley(Director)in

Co-investorsForesite CapitalJ2 VenturesMerck Global Health Innovation FundMSD Global Health Innovation FundOMX VenturesRA Capital+3 more

Theracletheracle.com

A medtech company developing a platform focused on treating neurological conditions and neurotherapeutics.

Deep TechHealthtechMedical Devices

WhiteSwellwhiteswell.comin

White Swell Limited was a company that has entered liquidation, with a liquidator appointed by the High Court in 2026; the site now serves only as a notice of the winding-up process and provides no description of its former business activity.

Co-investorsRA Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Cardiac PathwaysCorhythmEntrackFe3Fe3 MedicaliBridgeIntraPaceNeurolinkNFocusPercusurgePhysiometrixPythonRaniSacraMedSafeViewSymic BiomedicalVidamedZonare

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.